How to Play the Rebound in the Growing Canadian Cannabis Market

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news.

Subscribe to receive our free weekly newsletter in your inbox each Sunday morning.


2020 is ending with a strong rebound in cannabis stocks. With three weeks to go, the New Cannabis Ventures Global Cannabis Stock Index has rallied 151% off the March lows and is up 1% in 2020. The index has been led by American companies, as evidenced by the year-to-date performance of the New Cannabis Ventures American Cannabis Operator Index compared to the New Cannabis Ventures Canadian Cannabis LP Index.

The New Cannabis Ventures Canadian Cannabis LP Index has rallied a modest 40% off of its lows and is still down over 30% year-to-date. In sharp contrast to the weakness among Canadian LPs, three of the largest ones have posted strong gains, with Aphria increasing 74% year-to-date, Canopy Growth by 57% and Cronos Group by 43%. We have commented recently that the largest LPs appear to be rallying due to hope that the U.S. market may open to them, though we think this is an erroneous assessment of what lies ahead, as we discussed four weeks ago when we said that investors betting on legalization are buying the wrong stocks.

There may be more factors driving these large LPs than the optimism that the U.S. could open up. For one, international markets do appear to be finally gaining traction, and these LPs are poised to benefit. Also, the Canadian market is improving, with sales doubling year-over-year, according to Statistics Canada, as more stores open and new product formats launch.

The challenging roll out of adult-use cannabis in Canada left many of the LPs with too much production capacity and too much inventory, and the Canopy Growth announcement this week continues a trend of necessary asset impairments that will help bring supply and demand more into balance. Still, with such high market caps for these largest LPs, especially Canopy Growth at US$11 billion, we don’t expect a better Canadian market to necessarily drive their stocks higher.

As we look at the balance of the Canadian LP sector, we see much better values. Part of this is due technical pressure on some of the stocks, as we have seen some operators address weak balance sheets by selling stock or converting debt to equity, a process that has likely depressed their stocks while leaving them fundamentally stronger. Additionally, after two years of declining prices, many investors have written off the smaller LPs, leaving many to trade at relatively low ratios to their tangible book value or to their future expected sales and earnings. The large ETFs that hold Canadian LPs have narrowed their holdings and no longer own many of the names held previously.

For those who believe that the Canadian adult-use market is likely to continue its growth, we expect the best way to capitalize on it won’t be by buying the very largest LPs, which have already rallied substantially. Instead, select smaller LPs as well as retailers are likely better positioned to benefit from the expansion of retail stores in Ontario and BC and the roll out of more derivative products. With these smaller LPs, it’s important to assess their financial strength, management capability and growth strategy, as not all companies are well positioned.

Trichome Financial, which has already begun to prove its thesis with the purchase of JWC out of bankruptcy, is in a unique position as a platform to further consolidate and rationalize Canadian LP assets. It believes it has the opportunity to acquire additional operating assets with meaningful revenue and cash flow generation capability at a fraction of previously invested capital.

Get up to speed by visiting the Trichome Financial Investor Dashboard that we maintain on their behalf as a client of New Cannabis Ventures. Click the blue Follow Company button in order to stay up to date with their progress.

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:

To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.

Get ahead of the crowd! If you are a cannabis investor and find value in our Sunday newsletters, subscribe to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013. Gain immediate access to real-time and in-depth information and market intelligence about the publicly traded cannabis sector, including daily videos, weekly chats, model portfolios, a community forum and much more.

Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer a family of indices to track Canadian licensed producers as well as the American Cannabis Operator Index.

View the Public Cannabis Company Revenue & Income Tracker, which ranks the top revenue producing cannabis stocks that generate industry sales of more than US$12.5M per quarter.

Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.

Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.


Alan & Joel

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter